David Brookes
Follow
Get notifications in MyBN when activity occurs.
David Brookes
Non-Executive Director / Anatara Lifesciences
Dr David Brookes has experience in the health and biotechnology industries. He first became involved in the biotechnology sector in the late 1990s as an analyst, and continues to be a clinician and as a biotechnology industry consultant.
Dr Brookes has since held board positions in numerous ASX-listed biotechnology companies including as chair of genomics solutions company RHS, which was acquired by PerkinElmer Inc (NYSE:PKI $9B biotech company) in June 2018. He has also been a chair and member of several risk and audit committees in ASX-listed companies.
Dr Brookes is a Fellow of the Australian College of Rural and Remote Medicine, and a Fellow of the Australian Institute of Company Directors.
Dr Brookes has since held board positions in numerous ASX-listed biotechnology companies including as chair of genomics solutions company RHS, which was acquired by PerkinElmer Inc (NYSE:PKI $9B biotech company) in June 2018. He has also been a chair and member of several risk and audit committees in ASX-listed companies.
Dr Brookes is a Fellow of the Australian College of Rural and Remote Medicine, and a Fellow of the Australian Institute of Company Directors.
Lists and Charts
Total Shareholder Return as at 29/04/22
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1596th | Anatara Lifesciences | -46% | -38% |
1811 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Anatara Lifesciences | $1.1m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Non-Executive Director, TALI Digital | 03 Nov 2020 |
| NEW ROLE: Non-Executive Director, Anatara Lifesciences | 03 Nov 2020 |
